01:20 PM EDT, 07/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price by CAD3 to CAD232, based on 22x our 2026 EPS estimate of CAD10.55 (up from CAD10.42; 2025 revised to CAD9.66 from CAD9.59), compared to a 17x five-year average forward P/E. Our upward revisions to target price and EPS reflect strong Q2 and 1H 2025 results, with solid momentum heading into the back half of the year. L maintained its 2025 EPS outlook for high single-digit growth, but we model about 13% EPS growth this year, an acceleration from 11% in 2024, as both the food and drug retail segments are outperforming our expectations. Our Hold rating is primarily due to valuation, as L's trading multiple remains well above its historical average, a dynamic we are seeing across the food retail industry. We also applaud L's decision to explicitly label tariff-impacted items, which is encouraging more Canadians to buy local and pressuring suppliers to mitigate tariff-related costs in order to avoid the now-dreaded "T" label (a growing badge of shame).